NasdaqGS:ALNYBiotechs
A Look At Alnylam Pharmaceuticals’ (ALNY) Valuation After Recent Mixed Share Price Performance
What recent performance says about Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals (ALNY) has seen mixed share performance recently, with a small positive move over the past week and month, alongside a negative return in the past 3 months and year to date.
Given this context, the company’s current market value of about US$42.7b and last close of US$322.11 invite a closer look at how its RNA interference focused business and pipeline might be influencing sentiment.
See our latest...